Mandibular Advancement Devices Tali® in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas

The main objective is to evaluate middle term compliance (≥ 2 years) of the Mandibular Advancement Devices Tali® in patients with Syndrome of Obstructive Sleep Apnea and Hypopneas.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Syndrome of Obstructive Sleep Apnea and Hypopneas

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Liberal cabinet

Paris, 75008, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients > 18 years treated with Mandibular Advancement Device Tali® from at least 2 years and at the latest 5 years.
Patients who agree to participate to the study.

Treatment and study plan

Mandibular Advancement Devices

Device

Primary outcomes

compliance (no stop of the Mandibular Advancement Device)

Time frame: 2 years or more after the beginning of device

Sponsors and collaborators

Lead sponsor

ONIRIS

Industry

Registry information

Important dates

Study start: 2016
Primary completion: 2019
Study completion: 2019
First posted: Aug 25, 2016
Registry last updated: Aug 28, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.